Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Analytical Chemistry
  4. Fast Track Articles
  5. Fast Track Article
image of Stability of Tizanidine Hydrochloride: Photolytic Decomposition Kinetics and Identification of Degradation Products by UHPLC-QTOF/MS

Abstract

Background

Tizanidine hydrochloride (TZ) is a centrally acting skeletal muscle relaxant used in the management of spasticity. Drug stability under different conditions has been described in the literature, but photolytic degradation rate and degradation products are not known.

Objective

This study aimed to determine the TZ photolytic degradation kinetics and explore the structures of five degradation products observed after UV-C light exposure for 7 days.

Methodology

An HPLC method, previously validated, using a Phenyl Zorbax Eclipse XBD Agilent® column (250 mm x 4.6 mm, 5.0 μm), methanol, and water (50:50, ) with 0.5% trimethylamine pH adjusted to 3.5 with acid phosphoric mobile phase, at 0.6 mL/min flow rate, and 25ºC, was applied to drug quantification in the different time intervals. Mass spectrometry (UHPLC-QTOF-MS), using a Shim-pack XR-ODS III (50 X 2 mm, 1.6μm), was carried out to determine the structures of degradation products.

Results

Approximately 55.16% of the drug was degraded after 7 days under UV-C light. The photolytic reaction indicated the zero-order kinetics, with rate constant k = 2.48 days-1 and values for t and t of 6.04 and 1.20 days, respectively. Results were evaluated in order to suggest the chemical structures corresponding to respective masses and fragmentations.

Conclusion

Five degradation products, whose m/z values were 236, 268, 184, 186, and 216, were obtained, supporting the understanding of the TZ photostability profile.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cac/10.2174/0115734110361562250225071557
2025-03-06
2025-04-02

  • From This Site

    /content/journals/cac/10.2174/0115734110361562250225071557
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Awaad Y. Rizk T. Spasticity in children. J. Taibah Univ. Med. Sci. 2012 7 2 53 60 10.1016/j.jtumed.2012.12.004
    [Google Scholar]
  2. Qi M.L. Wang P. Wang L. Validated liquid chromatography method for assay of tizanidine in drug substance and formulated products. Anal. Chim. Acta 2003 478 2 171 177 10.1016/S0003‑2670(02)01525‑8
    [Google Scholar]
  3. The United States Pharmacopoeia 38th Ed Rockville United States Pharmacopoeial Convention 2015
    [Google Scholar]
  4. The Pharmacopoeia of Japan. 16th ed Tokyo Society of Japanese Pharmacopoeia 2011
    [Google Scholar]
  5. Gobetti C. Bitencourt A.S. Ayres M.V. Freitas A.L.P. Mendez A.S.L. Garcia C.V. Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern. Braz. J. Pharm. Sci. 2021 57 e18896 10.1590/s2175‑97902020000418896
    [Google Scholar]
  6. Tønnesen H.H. Formulation and stability testing of photolabile drugs. Int. J. Pharm. 2001 225 1-2 1 14 10.1016/S0378‑5173(01)00746‑3 11489550
    [Google Scholar]
  7. Li M. Organic Chemistry of Drug Degradation. Cambridge RSC Publishing 2012 10.1039/9781849735360
    [Google Scholar]
  8. Yoshioka S. Stella V. Stability of Drugs and Dosage Forms. New York Kluwer Academic/ Plenum Publishers 2000
    [Google Scholar]
  9. Zothanpuii R. Selvakumar K. Stability indicating RP-HPLC method development and validation for the analysis of tizanidine in bulk and pharmaceutical formulation. J. Pharm. Sci. Res. 2020 12 1162 1169
    [Google Scholar]
  10. Brandalise M. Ferreira L.P.C. Pereira G.A. Meneghini L. Fröehlich P.E. Bergold A.M. Stability-indicating method for determination of tizanidine hydrochloride by LC-CAD method using chemometric approach. Drug Ana. Res. 2017 1 1 61 66 10.22456/2527‑2616.75607
    [Google Scholar]
  11. Attia K. Nassar M. Abdel-fattah A. A comparative study of different approaches for stability-indicating determination of tizanidine in presence of its oxidative degradation product. Int. J. Pharm. Pharm. Res. 2016 5 166 195
    [Google Scholar]
  12. Mahadik K.R. Paradkar A.R. Agrawal H. Kaul N. Stability-indicating HPTLC determination of tizanidine hydrochloride in bulk drug and pharmaceutical formulations. J. Pharm. Biomed. Anal. 2003 33 4 545 552 10.1016/S0731‑7085(03)00304‑2 14623579
    [Google Scholar]
  13. Nudelman N. Estabilidad de Medicamentos. Buenos Aires El Atheneo 1975
    [Google Scholar]
  14. Mendez A.S.L. Dalomo J. Steppe M. Schapoval E.E.S. Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample. J. Pharm. Biomed. Anal. 2006 41 4 1363 1366 10.1016/j.jpba.2006.02.017 16533586
    [Google Scholar]
  15. Garcia C.V. Bitencourt A.S. Oliveira S.S. Gobetti C. Mendez A.S.L. Analytical Study of the antifungal posaconazole in raw material: Quantitative bioassay, decomposition chemical kinetics, and degradation impurities by LC-QTOF-MS. J. AOAC Int. 2021 104 4 1055 1064 10.1093/jaoacint/qsab009 33470411
    [Google Scholar]
  16. Sinko P. Martin - físico-farmácia e ciências farmacêuticas. 5th ed Porto Alegre Artmed 2000
    [Google Scholar]
  17. Barbosa F. Pezzi L. Sorrentino J. Steppe M. Volpato N. Mendez A.S.L. pH effect on stability and kinetics degradation of nitazoxanide in solution. Drug Ana. Res. 2020 4 1 12 17 10.22456/2527‑2616.101465
    [Google Scholar]
  18. Garcia C.V. Nudelman N.S. Steppe M. Schapoval E.E.S. Structural elucidation of rabeprazole sodium photodegradation products. J. Pharm. Biomed. Anal. 2008 46 1 88 93 10.1016/j.jpba.2007.09.002 17945453
    [Google Scholar]
  19. Sangoi M.S. Todeschini V. Goelzer G.K. Steppe M. Photochemistry of a novel antimuscarinic drug fesoterodine and identification of its photodegradation products by LC–ESI–MS studies. J. Photochem. Photobiol. Chem. 2013 256 16 22 10.1016/j.jphotochem.2013.02.003
    [Google Scholar]
  20. ICH Guideline - Stability testing of new drug substances and products Q1A (R2). International Conference on Harmonisation Geneva, 2003, pp. 1-24.
    [Google Scholar]
  21. ICH Guideline- Stability testing: Photostability testing of new drug substances and products Q1B. Geneva International Conference on Harmonisation 1996 172
    [Google Scholar]
  22. Gobetti C. Balsan M.E. Ayres M.V. Almeida d.S.H.O. de Saldanha Simon E. Wingert N.R. Oppe T.P. Garcia C.V. Development and stability control of pediatric oral tizanidine hydrochloride formulations for hospital use. AAPS PharmSci. 2020 21 6 210 220 10.1208/s12249‑020‑01751‑8 32729029
    [Google Scholar]
  23. Piechocki J. Thoma K. Pharmaceutical Photostability and Stabilization Technology. New York Informa Healthcare 2006 10.1201/9781420014136
    [Google Scholar]
  24. Thoma K. Klimek R. Photostabilization of drugs in dosage forms without protection from packaging materials. Int. J. Pharm. 1991 67 2 169 175 10.1016/0378‑5173(91)90429‑R
    [Google Scholar]
  25. Flores-Cervantes D.X. Palou E. López-Malo A. Efficacy of individual and combined UVC light and food antimicrobial treatments to inactivate Aspergillus flavus or A. niger spores in peach nectar. Innov. Food Sci. Emerg. Technol. 2013 20 244 252 10.1016/j.ifset.2013.08.003
    [Google Scholar]
  26. Ferrand C. Marc F. Fritsch P. Blanquat D.G.S. Influence of various parameters on the browning of potassium sorbate in the presence of amines. Food Addit. Contam. 2000 17 12 947 956 10.1080/02652030050207729 11271840
    [Google Scholar]
  27. Koch P. Hirst D.R. Wartburg v.B.R. Biological fate of sirdalud in animals and man. Xenobiotica 1989 19 11 1255 1265 10.3109/00498258909043177 2618078
    [Google Scholar]
  28. Granfors M. Backman J. Laitila J. Neuvonen P. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2. Clin. Pharmacol. Ther. 2005 78 4 400 411 10.1016/j.clpt.2005.06.009 16198659
    [Google Scholar]
  29. Peng S.X. Borah B. Dobson R.L.M. Liu Y.D. Pikul S. Application of LC-NMR and LC-MS to the identification of degradation products of a protease inhibitor in dosage formulations. J. Pharm. Biomed. Anal. 1999 20 1-2 75 89 10.1016/S0731‑7085(98)00311‑2 10704011
    [Google Scholar]
  30. Manoel J.W. Primieri G.B. Bueno L.M. Giordani C.F.A. Sorrentino J.M. Dallegrave A. Paim C.S. Schapoval E.E.S. Garcia C.V. Steppe M. Determination of empagliflozin in the presence of its organic impurities and identification of two degradation products using UHPLC-QTOF/MS. Microchem. J. 2021 161 105795 10.1016/j.microc.2020.105795
    [Google Scholar]
  31. Wu Y. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations. Biomed. Chromatogr. 2000 14 6 384 396 10.1002/1099‑0801(200010)14:6<384::AID‑BMC30>3.0.CO;2‑D 11002276
    [Google Scholar]
  32. Liang X. Liu Z. Shi H. Zhang Y. Wang S. Bi K. Chen X. Degradation kinetics of larotaxel and identification of its degradation products in alkaline condition. J. Pharm. Anal. 2017 7 2 118 122 10.1016/j.jpha.2016.11.002 29404026
    [Google Scholar]
/content/journals/cac/10.2174/0115734110361562250225071557
Loading
Stability of Tizanidine Hydrochloride: Photolytic Decomposition Kinetics and Identification of Degradation Products by UHPLC-QTOF/MS
Bentham Science Publishers ; https://doi.org/10.2174/0115734110361562250225071557
/content/journals/cac/10.2174/0115734110361562250225071557
/content/journals/cac/10.2174/0115734110361562250225071557
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Tizanidine ; HPLC ; UHPLC-QTOF-MS ; degradation kinetics ; UVC ; degradation products

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test